SBC Medical Group Holdings Incorporated (SBCWW)
| Market Cap | 416.53M +28.0% |
| Revenue (ttm) | 175.17M -14.4% |
| Net Income | 49.03M -17.4% |
| EPS | 0.48 -20.6% |
| Shares Out | 102.85M |
| PE Ratio | 8.50 |
| Forward PE | 7.97 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,710 |
| Open | 0.3050 |
| Previous Close | 0.3100 |
| Day's Range | 0.3050 - 0.3150 |
| 52-Week Range | 0.1000 - 0.3975 |
| Beta | 0.59 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |
About SBCWW
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procu... [Read more]
News
Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on SBC Medical Group Holdings Incorporated
NEW YORK CITY, NY / ACCESS Newswire / August 27, 2026 / Emerging Growth Research, LLC ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research quarterly upda...
SBC Medical Group Holdings Transcript: Q3 Investor Summit Group Virtual Conference 2026
The group reported strong revenue and profit growth, driven by clinic expansion, higher customer spending, and AI-enhanced operations. Strategic initiatives include multi-branding, global expansion, and a growing focus on non-aesthetic healthcare and longevity services.
Emerging Growth Research Releases Q2:26 Quarterly Update on SBC Medical Group; Reiterates Buy Rating and Increases Price Target to $11.00
NEW YORK CITY, NY / ACCESS Newswire / August 24, 2026 / Emerging Growth Research today announced the release of its Q2:26 Quarterly Update Report on SBC Medical Group Holdings (NASDAQ:SBC), reiteratin...
SBC Medical Group Holdings Transcript: Emerging Growth Conference
The group reported strong Q2 2026 growth, with revenue and profit rising on the back of structural reforms, AI-driven efficiency, and expansion in both aesthetic and non-aesthetic healthcare. Global partnerships and a focus on longevity and recurring revenue underpin future growth.
SBC Medical Group Holdings Slides: Corporate presentation
SBC Medical Group Holdings has posted slides in relation to its latest quarterly earnings report, which was published on August 19, 2026.
SBC Medical Group Holdings Earnings Call Transcript: Q2 2026
Q2 2026 saw accelerated profit and revenue growth, driven by AI-enabled efficiency, expanded clinic network, and strategic fee increases. Strong cash reserves support ongoing M&A and global expansion, with a focus on longevity and non-aesthetic healthcare for future growth.
SBC Medical Group Holdings Slides: Q2 2026
SBC Medical Group Holdings has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.
SBC Medical Group Holdings Earnings release: Q2 2026
SBC Medical Group Holdings released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
SBC Medical Group Holdings Quarterly report: Q2 2026
SBC Medical Group Holdings has published its Q2 2026 quarterly earnings report on August 13, 2026.
SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)-- #Healthcare--Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Up 335%, Adjusted EBITDA1 Up 32% Year-over-Year.
SBC Medical to Announce 2Q 2026 Financial Results
IRVINE, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support a...
SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET
IRVINE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support a...
SBC Medical Group Holdings Transcript: AGM 2026
The meeting, held virtually, covered director elections, auditor ratification, and several charter amendments, all of which were approved by stockholders. No questions were raised during the Q&A, and final voting results will be filed in a Form 8-K.
SBC Medical Launches Japan's First Specialized Men's Beard Hair Removal Clinic, Introducing a Scalable, Capital-Efficient Growth Platform
IRVINE, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support a...
SBC Medical Group Holdings Transcript: Sidoti Small-Cap Virtual Investor Conference
A scalable, data-driven multi-brand healthcare model underpins growth, with strong underlying revenue and EBITDA gains despite headline declines due to structural changes. Strategic initiatives focus on longevity, AI integration, and selective global expansion, supported by robust capital allocation and a unique competitive moat.
SBC Medical Group Holdings Transcript: Emerging Growth Conference 93
A scalable, asset-light franchise model and multi-brand strategy drive strong customer loyalty and profitability, with underlying revenue and EBITDA showing double-digit growth after adjusting for fee revisions. Growth initiatives focus on longevity, AI integration, and selective global expansion, aiming for international business to reach 25% of revenue in five years.
SBC Medical Group Holdings Slides: Investor presentation
SBC Medical Group Holdings has posted slides in relation to its latest quarterly earnings report, which was published on June 11, 2026.
SBC Medical Group Holdings Transcript: Noble Capital Markets June 2026 Emerging Growth Virtual Equity Conference
The group operates a scalable, multi-brand clinic network with strong customer loyalty and a 26-year data advantage. Despite a temporary revenue dip from fee structure changes, underlying growth remains robust, driven by higher average revenue per visit and expanding services. Strategic focus includes longevity, AI-driven efficiency, and selective global expansion.
SBC Medical Group Holdings Proxy statement: Proxy filing
SBC Medical Group Holdings filed a proxy statement on May 28, 2026, providing details for shareholder voting and corporate governance matters.
SBC Medical Group Holdings Proxy statement: Proxy filing
SBC Medical Group Holdings filed a proxy statement on May 28, 2026, providing details for shareholder voting and corporate governance matters.
SBC Medical will participate in several upcoming investor conferences in May and June 2026
IRVINE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support ac...
SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
Japanese-Quality Pico Laser Treatment to Serve the Growing Thai Aesthetic Healthcare Market, with Service Launch Scheduled for June 2026 Japanese-Quality Pico Laser Treatment to Serve the Growing Thai...
Emerging Growth Research Releases Q1:26 Quarterly Update on SBC Medical Group; Upgrades to Buy Rating and Increases Price Target to $10.00
NEW YORK CITY, NY / ACCESS Newswire / May 20, 2026 / Emerging Growth Research today announced the release of its Q1:26 Quarterly Update Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), upgradi...
SBC Medical Group Holdings Proxy statement: Proxy filing
SBC Medical Group Holdings filed a proxy statement on May 15, 2026, providing details for shareholder voting and corporate governance matters.
SBC Medical Group Holdings Earnings Call Transcript: Q1 2026
Q1 2026 revenue declined 9% year-over-year due to fee structure changes, but underlying revenue and EBITDA grew 11% and 17% respectively when adjusted. Clinic operations and ARPU improved, with AI and multi-brand strategies supporting future margin and growth.